Posted May 18, 2012 by Team AnalyticpediA in Analytics

Acquisiton of analytics by healthcare: Piramal -DRG

piramal analyticpedia
piramal analyticpedia

Piramal Healthcare on Wednesday took the first big step towards building a global pharma company focused on original discovery and intellectual property rights by buying an American health information provider capable of analysing and predicting industry trends. The purchase, which will cost Piramal Healthcare $635 million, will help the company’s nascent drug discovery business predict emerging trends and change its product portfolio accordingly.

By acquiring Decision Resources Group (DRG), a US-based healthcare information provider, for Rs3,400 crore ($635 million), Piramal Healthcare is venturing into a field where no major Indian pharma player has tread so far.

DRG’s business is spread across biopharma and medical technology, which automatically increases Piramal’s bandwidth.The deal is expected to close by June 30, subject to regulatory approvals. Post completion of the deal, Piramal will operate Decision Resources as a standalone business. It will remain headquartered at Burlington in Massachusetts, USA and will continue be led by Chief Executive Peter Hoenigsberg and the existing senior management team.

DRG, which counts American Forrester Research, the Gartner Group, Thomson Reuters and Reed Elsevier as rivals, provides web-enabled research, predictive analytics (a statistical technique to predict future market movements) and consulting services to pharma companies. The debt-free company, which has grown at a 20% compounded annual growth rate in the past five years, has projected revenues of $160 million for 2012, and has 48 of the top 50 global pharmaceutical companies as its clients.


Team AnalyticpediA

Avatar of Team AnalyticpediA
Team Analyticpedia pledge to grow even steeper than analytics and bring u the latest knowledge,news,happenings,reviews around the globe and beyond from the realms of analytics and technology.